Fibrinogen function indexes are potential biomarkers of diabetic peripheral neuropathy

Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and th...

Full description

Saved in:
Bibliographic Details
Published inDiabetology and metabolic syndrome Vol. 14; no. 1; pp. 13 - 7
Main Authors Zhuang, Yong, Lin, Xiahong, Chen, Xiaoyu, Wu, Xiaohong, Zhang, Jinying
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 18.01.2022
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored. This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls. Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle α levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle α with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051-0.124], P < 0.001; odds ratio 1.131 [1.063-1.204], P < 0.001). The k value and angle α levels were closely correlated with neuropathy stage (r  = - 0.686, P < 0.000; r  = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle α levels was 60°, with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669). The k value and angle α are closely associated with DPN. The levels of the k value and angle α may be helpful in the early diagnosis of DPN.
AbstractList Abstract Background and objectives Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored. Subjects and methods This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls. Results Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle α levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle α with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051–0.124], P < 0.001; odds ratio 1.131 [1.063–1.204], P < 0.001). The k value and angle α levels were closely correlated with neuropathy stage (r  = − 0.686, P < 0.000; r  = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle α levels was 60°, with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669). Conclusions The k value and angle α are closely associated with DPN. The levels of the k value and angle α may be helpful in the early diagnosis of DPN.
Background and objectives Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored. Subjects and methods This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls. Results Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle α levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle α with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051–0.124], P < 0.001; odds ratio 1.131 [1.063–1.204], P < 0.001). The k value and angle α levels were closely correlated with neuropathy stage (r  = − 0.686, P < 0.000; r  = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle α levels was 60°, with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669). Conclusions The k value and angle α are closely associated with DPN. The levels of the k value and angle α may be helpful in the early diagnosis of DPN.
Background and objectives Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle [alpha], reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored. Subjects and methods This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls. Results Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle [alpha] levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle [alpha] with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051-0.124], P < 0.001; odds ratio 1.131 [1.063-1.204], P < 0.001). The k value and angle [alpha] levels were closely correlated with neuropathy stage (r = - 0.686, P < 0.000; r = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle [alpha] levels was 60[degrees], with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669). Conclusions The k value and angle [alpha] are closely associated with DPN. The levels of the k value and angle [alpha] may be helpful in the early diagnosis of DPN. Keywords: Diabetic peripheral neuropathy, Fibrinogen, k value, Angle [alpha], Diagnosis
This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls. Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle [alpha] levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle [alpha] with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051-0.124], P < 0.001; odds ratio 1.131 [1.063-1.204], P < 0.001). The k value and angle [alpha] levels were closely correlated with neuropathy stage (r = - 0.686, P < 0.000; r = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle [alpha] levels was 60[degrees], with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669). The k value and angle [alpha] are closely associated with DPN. The levels of the k value and angle [alpha] may be helpful in the early diagnosis of DPN.
Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored. This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls. Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle α levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle α with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051-0.124], P < 0.001; odds ratio 1.131 [1.063-1.204], P < 0.001). The k value and angle α levels were closely correlated with neuropathy stage (r  = - 0.686, P < 0.000; r  = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle α levels was 60°, with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669). The k value and angle α are closely associated with DPN. The levels of the k value and angle α may be helpful in the early diagnosis of DPN.
Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored.BACKGROUND AND OBJECTIVESResearch suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored.This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls.SUBJECTS AND METHODSThis prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls.Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle α levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle α with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051-0.124], P < 0.001; odds ratio 1.131 [1.063-1.204], P < 0.001). The k value and angle α levels were closely correlated with neuropathy stage (r  = - 0.686, P < 0.000; r  = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle α levels was 60°, with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669).RESULTSFib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle α levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle α with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051-0.124], P < 0.001; odds ratio 1.131 [1.063-1.204], P < 0.001). The k value and angle α levels were closely correlated with neuropathy stage (r  = - 0.686, P < 0.000; r  = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle α levels was 60°, with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669).The k value and angle α are closely associated with DPN. The levels of the k value and angle α may be helpful in the early diagnosis of DPN.CONCLUSIONSThe k value and angle α are closely associated with DPN. The levels of the k value and angle α may be helpful in the early diagnosis of DPN.
ArticleNumber 13
Audience Academic
Author Lin, Xiahong
Wu, Xiaohong
Zhang, Jinying
Zhuang, Yong
Chen, Xiaoyu
Author_xml – sequence: 1
  givenname: Yong
  surname: Zhuang
  fullname: Zhuang, Yong
– sequence: 2
  givenname: Xiahong
  orcidid: 0000-0001-8445-818X
  surname: Lin
  fullname: Lin, Xiahong
– sequence: 3
  givenname: Xiaoyu
  surname: Chen
  fullname: Chen, Xiaoyu
– sequence: 4
  givenname: Xiaohong
  surname: Wu
  fullname: Wu, Xiaohong
– sequence: 5
  givenname: Jinying
  surname: Zhang
  fullname: Zhang, Jinying
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35042559$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1DAUhiNURC_wAixQJCTEJsWO49sGqaooVKrEBthajnMy8ZCxg50g-vac6ZQyUyGUhaPj7_zn4v-0OAoxQFG8pOScUiXeZcqIVhWpaUWIlLKST4oTKrmquNbiaO__uDjNeU2IkFw2z4pjxklTc65Pim9Xvk0-xBWEsl-Cm30MpQ8d_IJc2gTlFGcIs7dj2fq4sek7pFzGvuy8bWH2rpwg-WmAhESAJcXJzsPt8-Jpb8cML-7Ps-Lr1Ycvl5-qm88fry8vbirHdTNXoq2FVZQprgUFx62jRHPdMkKow4AQrpE9I0x2UgreONm1ulUtU0BtJwk7K653ul20azMljx3emmi9uQvEtDI2YZcjmBpqVjsunG5pg2W0Rfm-a7TC0rq1qPV-pzUt7QY6h2PjUAeihzfBD2YVfxolRSNlgwJv7wVS_LFAns3GZwfjaAPEJZta1LTmUlOO6OtH6DouKeCqthQ2xyVRf6mVxQF86CPWdVtRcyE0k4SKhiF1_g8Kvw423qFleo_xg4Q3ewkD2HEechyX7dvnQ_DV_kYeVvHHPgjUO8ClmHOC_gGhxGw9anYeNehRc-dRIzFJPUpyfrbb4ti3H_-X-ht8v-kD
CitedBy_id crossref_primary_10_1007_s12640_023_00657_0
crossref_primary_10_7759_cureus_74977
crossref_primary_10_4274_jcrpe_galenos_2021_2021_0148
crossref_primary_10_1186_s10020_023_00698_3
crossref_primary_10_3390_ph17091139
crossref_primary_10_1186_s12902_022_01185_2
crossref_primary_10_3389_fendo_2022_930271
crossref_primary_10_1007_s12020_024_03689_4
crossref_primary_10_1111_cns_70040
crossref_primary_10_3389_fendo_2025_1501323
crossref_primary_10_3389_fendo_2023_1143067
Cites_doi 10.1097/00001721-199509000-00011
10.1016/j.ejphar.2013.07.017
10.1016/j.neulet.2014.11.020
10.2337/db20182-1
10.1001/jama.2013.168118
10.1016/j.dsx.2015.10.011
10.1056/NEJMoa0908292
10.1007/s11892-003-0006-0
10.1371/journal.pone.0153389
10.1055/s-2004-830524
10.1097/WNP.0000000000000522
10.1016/j.diabres.2018.02.023
10.1016/j.diabres.2016.01.002
10.4172/2155-6156
10.1097/MD.0000000000001783
10.1530/EJE-14-0381
10.1016/j.vph.2017.03.005
10.1159/000081919
10.1016/S2213-8587(19)30081-6
10.1056/NEJMc1004671
10.1016/j.actbio.2016.09.024
10.2337/dc13-0590
10.1016/S1056-8727(00)00132-X
10.1016/j.neucli.2018.03.001
10.1002/ana.410080608
10.2310/7750.2013.WOUND3
ContentType Journal Article
Copyright 2022. The Author(s).
COPYRIGHT 2022 BioMed Central Ltd.
2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2022
Copyright_xml – notice: 2022. The Author(s).
– notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2022
DBID AAYXX
CITATION
NPM
3V.
7QP
7TS
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s13098-021-00777-7
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Physical Education Index
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Physical Education Index
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database


PubMed
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1758-5996
EndPage 7
ExternalDocumentID oai_doaj_org_article_2e232c56c9b141099ac66fd49861e9ba
PMC8764774
A693701643
35042559
10_1186_s13098_021_00777_7
Genre Journal Article
GeographicLocations Germany
GeographicLocations_xml – name: Germany
GrantInformation_xml – fundername: Startup Fund for scientific research, Fujian Medical University
  grantid: 2020QH1118
– fundername: ;
  grantid: 2020QH1118
GroupedDBID ---
0R~
53G
5VS
7X7
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
DIK
E3Z
EBD
EBLON
EBS
ESX
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IEA
IHR
IHW
ITC
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TUS
U2A
UKHRP
-5E
-5G
-A0
-BR
3V.
ACRMQ
ADINQ
C24
NPM
PMFND
7QP
7TS
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c594t-6b26a81385961ec5ac10959b3001c1ec66c47f3037d77654c7db9b8b38e1ad703
IEDL.DBID DOA
ISSN 1758-5996
IngestDate Wed Aug 27 01:25:17 EDT 2025
Thu Aug 21 13:57:40 EDT 2025
Thu Jul 10 23:15:01 EDT 2025
Mon Jun 30 03:52:45 EDT 2025
Tue Jun 17 21:39:48 EDT 2025
Tue Jun 10 20:23:08 EDT 2025
Thu May 22 21:23:32 EDT 2025
Thu Jan 02 22:55:04 EST 2025
Tue Jul 01 01:26:45 EDT 2025
Thu Apr 24 23:08:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Diagnosis
Diabetic peripheral neuropathy
Angle α
k value
Fibrinogen
Language English
License 2022. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c594t-6b26a81385961ec5ac10959b3001c1ec66c47f3037d77654c7db9b8b38e1ad703
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-8445-818X
OpenAccessLink https://doaj.org/article/2e232c56c9b141099ac66fd49861e9ba
PMID 35042559
PQID 2620995708
PQPubID 54993
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_2e232c56c9b141099ac66fd49861e9ba
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8764774
proquest_miscellaneous_2621257915
proquest_journals_2620995708
gale_infotracmisc_A693701643
gale_infotracacademiconefile_A693701643
gale_healthsolutions_A693701643
pubmed_primary_35042559
crossref_primary_10_1186_s13098_021_00777_7
crossref_citationtrail_10_1186_s13098_021_00777_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-01-18
PublicationDateYYYYMMDD 2022-01-18
PublicationDate_xml – month: 01
  year: 2022
  text: 2022-01-18
  day: 18
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Diabetology and metabolic syndrome
PublicationTitleAlternate Diabetol Metab Syndr
PublicationYear 2022
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References C Hile (777_CR11) 2003; 3
Z Zhao (777_CR19) 2016; 115
Y Xu (777_CR1) 2013; 310
C Erem (777_CR26) 2005; 14
J Li (777_CR7) 2013; 36
MN Thabit (777_CR5) 2018; 35
T Kwok (777_CR28) 2013; 17
PJ Dyck (777_CR18) 1980; 8
ME Carr (777_CR15) 2001; 15
M Iftikhar (777_CR27) 2014; 26
AJM Boulton (777_CR4) 2018
NC Kwai (777_CR23) 2016; 11
CP Yang (777_CR22) 2015; 94
W Yang (777_CR2) 2010; 362
ME Carr Jr (777_CR25) 1995; 6
V Fonseca (777_CR21) 2006; 29
D Selvarajah (777_CR6) 2019; 7
H Yuan (777_CR20) 2012; S5
NH Cho (777_CR3) 2018; 138
PS Van Dam (777_CR16) 2013; 719
T Behl (777_CR24) 2017; 92
G Hussain (777_CR10) 2016; 10
F Gholami (777_CR12) 2018; 48
W Yang (777_CR17) 2010; 362
T Zhu (777_CR9) 2015; 12
E Coban (777_CR14) 2005; 113
JY Hsieh (777_CR13) 2017; 47
Y Hu (777_CR8) 2014; 171
References_xml – volume: 6
  start-page: 567
  issue: 6
  year: 1995
  ident: 777_CR25
  publication-title: Blood Coagul Fibrinolysis
  doi: 10.1097/00001721-199509000-00011
– volume: 719
  start-page: 180
  issue: 13
  year: 2013
  ident: 777_CR16
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2013.07.017
– volume: 12
  start-page: 28
  issue: 585
  year: 2015
  ident: 777_CR9
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2014.11.020
– year: 2018
  ident: 777_CR4
  publication-title: Arlington American Diabetes Association
  doi: 10.2337/db20182-1
– volume: 310
  start-page: 948
  issue: 9
  year: 2013
  ident: 777_CR1
  publication-title: JAMA
  doi: 10.1001/jama.2013.168118
– volume: 10
  start-page: S135
  issue: 1
  year: 2016
  ident: 777_CR10
  publication-title: Diabetes Metab Syndr
  doi: 10.1016/j.dsx.2015.10.011
– volume: 362
  start-page: 1090
  issue: 12
  year: 2010
  ident: 777_CR2
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0908292
– volume: 3
  start-page: 446
  issue: 6
  year: 2003
  ident: 777_CR11
  publication-title: Curr Diab Rep
  doi: 10.1007/s11892-003-0006-0
– volume: 11
  issue: 4
  year: 2016
  ident: 777_CR23
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0153389
– volume: 113
  start-page: 35
  issue: 1
  year: 2005
  ident: 777_CR14
  publication-title: Exp Clin Endocrinol Diabetes
  doi: 10.1055/s-2004-830524
– volume: 35
  start-page: 474
  issue: 6
  year: 2018
  ident: 777_CR5
  publication-title: J Clin Neurophysiol
  doi: 10.1097/WNP.0000000000000522
– volume: 29
  start-page: S3
  issue: Suppl 1
  year: 2006
  ident: 777_CR21
  publication-title: Diabetes Care.
– volume: 138
  start-page: 271
  year: 2018
  ident: 777_CR3
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2018.02.023
– volume: 115
  start-page: 50
  issue: 1
  year: 2016
  ident: 777_CR19
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2016.01.002
– volume: S5
  start-page: 007
  year: 2012
  ident: 777_CR20
  publication-title: J Diabetes Metab
  doi: 10.4172/2155-6156
– volume: 94
  issue: 42
  year: 2015
  ident: 777_CR22
  publication-title: Medicine
  doi: 10.1097/MD.0000000000001783
– volume: 171
  start-page: 641
  issue: 5
  year: 2014
  ident: 777_CR8
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-14-0381
– volume: 92
  start-page: 1
  year: 2017
  ident: 777_CR24
  publication-title: Vascul Pharmacol
  doi: 10.1016/j.vph.2017.03.005
– volume: 14
  start-page: 22
  issue: 1
  year: 2005
  ident: 777_CR26
  publication-title: Med Princ Pract
  doi: 10.1159/000081919
– volume: 7
  start-page: 938
  issue: 12
  year: 2019
  ident: 777_CR6
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(19)30081-6
– volume: 362
  start-page: 2425
  issue: 25
  year: 2010
  ident: 777_CR17
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc1004671
– volume: 47
  start-page: 14
  year: 2017
  ident: 777_CR13
  publication-title: Acta Biomater
  doi: 10.1016/j.actbio.2016.09.024
– volume: 36
  start-page: 3405
  issue: 11
  year: 2013
  ident: 777_CR7
  publication-title: Diabetes Care
  doi: 10.2337/dc13-0590
– volume: 15
  start-page: 44
  issue: 1
  year: 2001
  ident: 777_CR15
  publication-title: Diab Complic
  doi: 10.1016/S1056-8727(00)00132-X
– volume: 26
  start-page: 584
  issue: 4
  year: 2014
  ident: 777_CR27
  publication-title: J Ayub Med Coll Abbottabad
– volume: 48
  start-page: 195
  issue: 4
  year: 2018
  ident: 777_CR12
  publication-title: Neurophysiol Clin
  doi: 10.1016/j.neucli.2018.03.001
– volume: 8
  start-page: 590
  issue: 6
  year: 1980
  ident: 777_CR18
  publication-title: Ann Neurol
  doi: 10.1002/ana.410080608
– volume: 17
  start-page: S1
  issue: Suppl 1
  year: 2013
  ident: 777_CR28
  publication-title: J Cutan Med Surg
  doi: 10.2310/7750.2013.WOUND3
SSID ssj0067574
Score 2.3199801
Snippet Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function...
Background and objectives Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its...
This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic...
Abstract Background and objectives Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 13
SubjectTerms Angle α
Asymptomatic
Biomarkers
Blood pressure
Cholesterol
Creatinine
Diabetes
Diabetes mellitus (non-insulin dependent)
Diabetic neuropathies
Diabetic neuropathy
Diabetic peripheral neuropathy
Diabetic retinopathy
Diagnosis
Disease
Fibrin
Fibrinogen
Glucose
Growth factors
Hospitals
k value
Liver
Medical diagnosis
Metabolism
Patients
Peripheral neuropathy
Plasma
Statistical analysis
Type 2 diabetes
Vitamin deficiency
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k3aAkFC4oCi5uHnCRXEqkIqJ4r2ZtkTBypVybLZHvj3zDje0Aip13i8Wo_nZXvmG8beOaErcLoqXAlQcKl5oXWAogmuA9068C296J5_k2cX_OtarNOF25jSKvc2MRrqdgC6Iz8h4HRjhCr1x83vgrpG0etqaqFxl90j6DJK6VLr-cCFsbDi-0IZLU9GtNdUUFbjAbpUShVq4YwiZv__lvmGa1qmTd7wQ6tH7GEKIPPTaccfszuhf8Lun6cn8qfsx4qS-PsBBSMnp0WMzyMmYhhztw35ZthRhhD-BpXeU3bOdsyHLp9uYS8hJ-zjCDZwlUe0S2pa_OcZu1h9-f75rEjNEwoQhu8K6WuJe9BoYWQVQDio6MrPN-iXAD9ICVx16MBUq5QUHFTrjde-0aFyLdqB5-ygH_rwkuVeBCHaui1xhIOunRKAqi4CTq-7rs5YteeihYQsTg0urmw8YWhpJ85b5LyNnLcqYx_mOZsJV-NW6k-0OTMlYWLHD8P2p00qZuuA0SEICcZT8qoxDhfZtdxoZIDxLmNvaGvtVGA6a7Y9lRiiEdJYk7H3kYJ0GxcALpUoIBsIJWtBebygRJ2E5fBefGyyCaP9J8EZezsP00zKc-vDcB1pMOJUphIZezFJ27zoRpCBFSZjaiGHC64sR_rLXxExHF0exzj_8Pa_dcQe1FTcUVZFpY_ZwW57HV5hyLXzr6Ne_QUU1iow
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9VAEF9qBfEifptaNYLgQaIvyX4eRKr4KMLz5JPelt3JphYeSc17hfa_d2bzQYPFk9fd2cDOx85sduY3jL1xQufgdJ65BUDGpeaZ1gGyMrgadOXAV_Siu_ouj9f824k42WNju6OBgdsbr3bUT2rdbd5f_r76hAb_MRq8lh-2eA5ToViBF-OFUipTt9ht9EyKDHXFp1cFjI0VHwtnblw3c04Rw__vk_qaq5qnUV7zS8v77N4QUKZHvQY8YHuhecjurIYn80fs55KS-psWFSUlJ0aCSCNGYtimrgvpebujjCH8BpXiU7ZOt03bOu3_yp5BSljIEXxgk0b0S2pifPWYrZdff3w5zoZmChkIw3eZ9IVEmZRaGJkHEA5y-gXoS_RTgANSAlc1OjRVKSUFB1V547UvdchdhefCE7bftE14xlIvghBVUS1whoMunBKApi8CLi_qukhYPnLRwoA0Tg0vNjbeOLS0Pectct5GzluVsHfTmvMeZ-Of1J9JOBMlYWTHgbY7tYPJ2SJgtAhCgvGUzGqMw03WFTcaGWC8S9grEq3tC04nS7dHEkM2Qh4rE_Y2UpD24QbADSULyAZCzZpRHs4o0UZhPj2qjx1V3FIrAGOEWuiEvZ6maSXlvTWhvYg0GIEqk4uEPe21bdp0KejAFSZhaqaHM67MZ5qzXxFBHF0gx7j_4H-w8Tm7W1BJyCLPcn3I9nfdRXiBgdrOv4zW9wcfhTo3
  priority: 102
  providerName: Scholars Portal
Title Fibrinogen function indexes are potential biomarkers of diabetic peripheral neuropathy
URI https://www.ncbi.nlm.nih.gov/pubmed/35042559
https://www.proquest.com/docview/2620995708
https://www.proquest.com/docview/2621257915
https://pubmed.ncbi.nlm.nih.gov/PMC8764774
https://doaj.org/article/2e232c56c9b141099ac66fd49861e9ba
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9RAFB-0gngRv02t6wiCBwndJPN5bKVrEbaIWNnbMPMywUJJyu724H_f9ybZsEHQi5ccMm9C8sv7muS93zD2wUtTgDdF7ucAuVBG5MZEyKvoGzC1h1DTH93lhTq_FF9XcrW31RfVhPX0wD1wx2XEmA9SgQ1UkmitB6WaWlijimhDSo0w5u0WU70PxixYi12LjFHHG_TU1EpW4tJ5rrXO9SQMJbb-P33yXlCaFkzuRaDFE_Z4SB35SX_LT9m92D5jD5fDz_Hn7OeCyvfbDlWCU7giyHliQ4wb7teR33Rbqg3Ca1DTPdXlrDe8a3j__fUKOLEeJ5qBa554Lmm74t8v2OXi7Mfn83zYNiEHacU2V6FUiH5lpEWIQHoo6GNfqDAiAZ5QCoRuMHTpWmslBeg62GBCZWLha_QAL9lB27XxNeNBRinrsp7jiABTei0BjVxGnF42TZmxYoeig4FTnLa2uHZpbWGU65F3iLxLyDudsU_jnJueUeOv0qf0ckZJYsNOJ1BH3KAj7l86krF39Gpd31o62rQ7UZicEcdYlbGPSYKsGh8A_NCcgDAQP9ZE8mgiidYI0-Gd-rjBG2wckf5bK_XcZOz9OEwzqcKtjd1tksFcU9tCZuxVr23jQ1eSXKu0GdMTPZygMh1pr34lrnAMdgIz_MP_AeMb9qik5o95kRfmiB1s17fxLaZk2zBj9_VKz9iD07OLb99nyRbx-GVV4HEpzB3WRzaz
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8ChQYJxAFF3Tz8OiDUQldb2l0h1KLeXMdxaKUq2e5uhfqn-I3MOMnSCKm3XuOxFY_HM2N75huAd4bJ2BoZR2ZobZRxmUVSOhulzpRWFsbmBb3oTqZ8fJR9O2bHa_Cny4WhsMpOJ3pFXdSW7si3CDhdKSaG8vPsIqKqUfS62pXQaMRi3139xiPb4tPeV1zf90ky2j38Mo7aqgKRZSpbRjxPOP5cKpnisbPM2JjuwvIUFbbFD5zbTJSo2UUhBGeZFUWucpmn0sWmwA2C496B9SzFo8wA1nd2p99_dLofvW-Rdak5km8t0EJQCluCR_ahECISPfPnqwT8bwuuGcN-oOY1yzd6CA9alzXcbmTsEay56jHcnbSP8k_g54jSBqoaRTEkM0lLHXoURrcIzdyFs3pJMUk4BiX7UzzQfBHWZdjc-57ZkNCWPbzBeejxNalM8tVTOLoVxj6DQVVX7gWEOXOMFUkxxJbMysQIZlG5MIfdk7JMAog7LmrbYplTSY1z7c80kuuG8xo5rz3ntQjg46rPrEHyuJF6hxZnRUko3P5DPf-l202tE4f-qGXcqpzCZZUyOMmyyJREBqjcBLBJS6ublNaVLtHbHJ1CwjZLA_jgKUib4ASsaZMikA2Ey9Wj3OhRohaw_eZOfHSrhRb6354J4O2qmXpSZF3l6ktPgz6uUDEL4HkjbatJp4xUOlMBiJ4c9rjSb6nOTj1GORrZDE8WL2_-rU24Nz6cHOiDven-K7ifUGrJMI5iuQGD5fzSvUaHb5m_aXdZCCe3vbH_AubfZyE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fibrinogen+function+indexes+are+potential+biomarkers+of+diabetic+peripheral+neuropathy&rft.jtitle=Diabetology+and+metabolic+syndrome&rft.au=Yong+Zhuang&rft.au=Xiahong+Lin&rft.au=Xiaoyu+Chen&rft.au=Xiaohong+Wu&rft.date=2022-01-18&rft.pub=BMC&rft.eissn=1758-5996&rft.volume=14&rft.issue=1&rft.spage=1&rft.epage=7&rft_id=info:doi/10.1186%2Fs13098-021-00777-7&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_2e232c56c9b141099ac66fd49861e9ba
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-5996&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-5996&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-5996&client=summon